Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice

European Journal of Immunology

Volumn 45, Issue 11, 2015, Pages 3126-3139

  Matisz, Chelsea E ^a   Leung, Gabriella ^a   Reyes, Jose Luis ^a   Wang, Arthur ^a   Sharkey, Keith A ^a,b   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colitis; Dendritic cells; Helminth antigen; Hymenolepis diminuta antigen; IL 10

Indexed keywords

ANTIGEN; HYMENOLEPIS DIMINUTA ANTIGEN; INTERLEUKIN 10; UNCLASSIFIED DRUG; PARASITE ANTIGEN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; FLOW CYTOMETRY; HYMENOLEPIS DIMINUTA; IMMUNOLOGY; KNOCKOUT MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, HELMINTH; COLITIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HYMENOLEPIS DIMINUTA; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT;

EID: 84951568224     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545579     Document Type: Article

References (53)

1. Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I. et al., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012.142: 46-54.
2. Allen, J. E. and Maizels, R. M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011.11: 375-388.
3. Maizels, R. M., Balic, A., Gomez-Escobar, N., Nair, M., Taylor, M. D. and Allen, J. E., Helminth parasites-masters of regulation.Immunol. Rev. 2004.201: 89-116.
4. + T cells enhancing their capacity to prevent colitis. J. Immunol. 2013, 191: 1927-1934.
5. Blum, A. M., Hang, L., Setiawan, T., Urban, J. P. J., Stoyanoff, K. M., Leung, J. and Weinstock, J. V., Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J. Immunol. 2012. 189: 2512-2520.
6. Hunter, M. M., Wang, A., Hirota, C. L. and McKay, D. M., Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced arthritis. J. Immunol. 2005.174: 7368-7375.
7. Summers, R. W., Elliott, D. E. and Urban, J. F., Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128: 825-832.
8. Weinstock, J. V. and Elliott, D. E., Helminth infections decrease host susceptibility to immune-mediated diseases. J. Immunol. 2014.193: 3239-3247.
9. Motomura, Y., Wang, H., Deng, Y., El-Sharkawy, R. T., Verdu, E. F. and Khan, W. I., Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin. Exp. Immunol. 2009.155: 88-95.
10. Ruyssers, N. E., De Winter, B. Y., De Man, J. G., Loukas, A., Pearson, M. S., Weinstock, J. V., Van den Bossche, R. M. et al., Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm. Bowel. Dis. 2009.15: 491-500.
11. Johnston, M. J., Wang, A., Catarino, M. E., Ball, L., Phan, V. C., MacDonald, J. A. and McKay, D. M., Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect. Immun. 2010.78: 1364-1375.
12. Harnett, M. M., Melendez, A. J. and Harnett, W., The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin. Exp. Immunol. 2010.159: 256-267.
13. McSorley, H. J., Blair, N. F., Smith, K. A., McKenzie, A. N. and Maizels, R. M., Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol. 2014.7: 1068-1078.
14. Robinson, M. W., Donnelly, S., Hutchinson, A. T., To, J., Taylor, N. L., Norton, R. S., Perugini, M. A. and Dalton, J. P., A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog. 2011.7: e1002042.
15. van Liempt, E., van Vliet, S. J., Engering, A., Garcia Vallejo, J. J., Bank, C. M., Sanchez-Hernandez, M., van Kooyk, Y. and van Die, I., Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 2007.44: 2605-2615.
16. + regulatory T cells. PLoS ONE. 2012.7: e40356.
17. Leung, G., Wang, A., Fernando, M., Phan, V. C. and McKay, D. M., Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10. Am. J. Physiol. Gastrointest. Liver Physiol. 2013.304: G781-92.
18. Reyes, J. L., Wang, A., Fernando, M. R., Graepel, R., Leung, G., van Rooijen, N., Sigvardsson, M. and McKay, D. M., Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages. J. Immunol. 2015.194: 364-378.
19. Ben-Ami Shor, D., Harel, M., Eliakim, R. and Shoenfeld, Y., The hygiene theory harnessing helminths and their ova to treat autoimmunity. Clin. Rev. Allergy Immunol.2013.45: 211-216.
20. Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R. and Weinstock, J. V., Trichuris suis therapy in Crohn's disease. Gut 2005.54: 87-90.
21. Johnston, M. J., MacDonald, J. A. and McKay, D, M., Parasitic helminths: a pharmacopeia of anti-inflammatory molecules. Parasitology 2009.136: 125-147.
22. Correale, J. and Farez, M., Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J. Immunol. 2009, 183: 5999-6012.
23. Melon, A., Wang, A., Phan, V. and McKay, D. M., Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. J. Biomed. Biotechnol. 2010.2010: 384523.
24. Goodridge, H. S., Marshall, F. A., Else, K. J., Houston, K. M., Egan, C., Al-Riyami, L., Liew, F. Y. et al., Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 2005.174: 284-293.
25. Falcon, C., Carranza, F., Martinez, F. F., Knubel, C. P., Masih, D. T., Motran, C. C. and Cervi, L., Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells. Vet. Immunol. Immunopathol. 2010.137: 36-46.
26. Casaravilla, C., Pittini, A., Ruckerl, D., Seoane, P. I., Jenkins, S. J., MacDonald, A. S., Ferreira, A. M. et al., Unconventional maturation of dendritic cells induced by particles from the laminated layer of larval Echinococcus granulosus. Infect. Immun. 2014.82: 3164-3176.
27. Dissanayake, S. and Shahin, A., Induction of interferon-γ by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells. Mol. Immunol. 2007.44: 1623-1630.
28. Danilowicz-Luebert, E., O'Regan, N. L., Steinfelder, S. and Hartmann, S., Modulation of specific and allergy-related immune responses by helminths. J. Biomed. Biotechnol. 2011.2011: 1-18.
29. Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hebuterne, X., Bouhnik, Y., Nachury, M. et al., Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 2012.143: 1207-17.
30. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R., Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 1996.2: 52-58.
31. Morse, M. A., Niedzwiecki, D., Marshall, J. L., Garrett, C., Chang, D. Z., Aklilu, M., Crocenzi, T. S. et al., A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann. Surg. 2013.258: 879-886.
32. Iclozan, C., Antonia, S., Chiappori, A., Chen, D. T. and Gabrilovich, D., Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunol. Immunother 2013.62: 909-918.
33. Tel, J., Aarntzen, E. H., Baba, T., Schreibelt, G., Schulte, B. M., Benitez-Ribas, D., Boerman, O. C. et al., Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res. 2013.73: 1063-1075.
34. Garcia, F., Plana, M., Climent, N., Leon, A., Gatell, J. M. and Gallart, T., Dendritic cell based vaccines for HIV infection: the way ahead. Hum. Vaccin Immunother 2013.9: 2445-2452.
35. Gonzalez-Rey, E. and Delgado, M., Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology 2006.131: 1799-1811.
36. Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J. C., Pot, B. and Grangette, C., A key role of dendritic cells in probiotic functionality. PLoS ONE 2007.2: e313.
37. Leech, M. D. and Grencis, R. K., Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells. J. Immunol. 2006.176: 2505-2511.
38. Liu, J. Y., Li, L. Y., Yang, X. Z., Li, J., Zhong, G., Wang, J., Li, L. J. et al., Adoptive transfer of dendritic cells isolated from helminth-infected mice enhanced T regulatory cell responses in airway allergic inflammation. Parasite Immunol. 2011.33: 525-534.
39. Sofronic-Milosavljevic, L. J., Radovic, I., Ilic, N., Majstorovic, I., Cvetkovic, J. and Gruden-Movsesijan, A., Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis. Med. Microbiol. Immunol. 2013.202: 239-249.
40. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 2001.19: 683-765.
41. Kuhn, R., Lohler, J., Rennick, D. M., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993.75: 263-274.
42. Duchman, R., Schmitt, E., Knolle, P., Meyer Zum Buschemfelde, K. H. and Neurath, M. F., Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 1996.26: 934-938.
43. Lindsay, J., Van Montfrans, C., Brennan, F., Van Deventer, S., Drillenburg, P., Hodgson, H., Te Velde, A. and Sol Rodriguez Pena, M., IL-10 gene therapy prevents TNBS-induced colitis. Gene Ther. 2002, 9: 1715-1721.
44. Franke, A., Balschun, T., Karlsen, T. H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F. S. et al., Sequence variants in IL-10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 2008.40: 1319-1323.
45. Buruiana, F. E., Sola, I. and Alonso-Coello, P., Recombinant human interleukin 10 for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 2010.11
46. Herfarth, H. and Scholmerich, J., IL-10 therapy in Crohn's disease: at the crossroads. Gut 2002.50: 146-147.
47. Zaccone, P., Burton, O., Miller, N., Jones, F. M., Dunne, D. W. and Cooke, A., Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 2009.39: 1098-1107.
48. + T cells and protects against mucosal inflammation. J. Immunol. 2015.194: 1555-1564.
49. Khan, W. I., Blennerhasset, P. A., Varghese, A. K., Chowdhury, S. K., Omsted, P., Deng, Y. and Collins, S. M., Intestinal nematode infection ameliorates experimental colitis in mice. Infect. Immun. 2002.70: 5931-5937.
50. Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Robner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999.223: 77-92.
51. Hollenbach, E., Vieth, M., Roessner, A., Neumann, M., Malfertheiner, P. and Naumann, M., Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J. Biol. Chem. 2005.280: 14981-14988.
52. Schicho, R., Bashashati, M., Bawa, M., McHugh, D., Saur, D., Hu, H. M., Zimmer, A. et al., The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm. Bowel Dis. 2011.17: 1651-1664.
53. Diaz-Granados, N., Howe, K., Lu, J. and McKay, D. M., Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am. J. Pathol. 2000.156: 2169-2177.